(NASDAQ:RVYL), New Strategic Partnerships with The Hockey News and Expansion of Elite Journalist Network to 150+ Former Sports Illustrated Media Professionals SAN DIEGO, CA, Jan. 07, 2026 (GLOBE NEWSWIRE) — RYVYL Inc. (NASDAQ: RVYL) (“RYVYL” or the “Company”) today highlighted recent developments achieved by its planned merger partner, Roundtable, including a long-term strategic partnership with […]

(NASDAQ:SABS),(NASDAQ:SABSW), David Zaccardelli, Pharm.D. joins Board as Chair Rita Jain, M.D., joins Board as an Independent Director MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced the appointment of David

(NasdaqGM:CAPT),(NASDAQ:MGI), MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) — Captivision Inc. (“Captivision” or the “Company”) (Nasdaq: CAPT), today announced that it has been informed that the Nasdaq Hearings Panel (the “Panel”) has granted the Company's request to extend the deadline for regaining compliance with the Nasdaq Listing Rules, subject to certain conditions related to the Company's

(NASDAQ:OSS), Initial design and prototype order valued at approximately $1.2 million Integration of OSS hardware into prime contractor system further validates OSS capabilities for next-generation 360-degree vision and sensor processing solutions ESCONDIDO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (OSS or the Company) (Nasdaq: OSS), a leader in rugged Enterprise Class

Premier Market & Patient Access: Hayden is renowned for resolving the industry's most complex payer, reimbursement, and affordability obstacles for global brands. Expansive Advisory Practice: BGB Strategic Advisory practice provides breakthrough solutions across commercial portfolios and brand lifecycles from Commercial Due Diligence, New Product Planning, Go-to-Market Strategies, and Market Access and Patient Services Strategic Consulting.

MORRISVILLE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) — Science 37, the leader in expanding patient access to clinical trials, today announced it has been named a finalist for two prestigious SCOPE Awards: the Participant Engagement Award and the Site Innovation Award. This marks the first time that a single company has been named a finalist

SAN DIEGO, Jan. 07, 2026 (GLOBE NEWSWIRE) — Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., president and chief executive officer of Recludix, will present an overview of the company's progress at the Annual J.P. Morgan Healthcare Conference in

Diginex Limited Announces Signing of Definitive Agreement to Acquire Plan A, Creating One of Europe's Leading Integrated ESG, Carbon Accounting and Decarbonization Platforms The combined business will deliver a single sophisticated platform to expand beyond existing strategic relationships, including HSBC, Coca Cola, Visa, and BMW. GlobeNewswire January 07, 2026 LONDON, Jan. 07, 2026 (GLOBE NEWSWIRE)

(NASDAQ:OPRX), WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life science companies reach and engage healthcare professionals (HCPs) and patients, today announced at CES 2026 a data collaboration with Experian, a leading global data and technology company. This integration maps OptimizeRx

(NASDAQ:PCRX), BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference at 11:15 AM PST (2:15 PM EST) on Wednesday,